HMA-EMA Joint Big Data Taskforce Updates

21st January 2020

The joint Big Data Task Force of EMA and the Heads of Medicines Agencies (HMA) proposes ten priority actions for the European medicines regulatory network to evolve its approach to data use and evidence generation, in order to make best use of big data to support innovation and public health, in a report published on the 20th January 2020.

Click here for the Phase II report, and here for their ten priority actions.